Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061207) titled 'Development of Early Support for Recovery in Individuals with Psychiatric and Neurodevelopmental Disorders' on April 10.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - The University of Tokyo
Condition:
Condition - Psychiatric and Neurodevelopmental Disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effectiveness of a brief support aimed at promoting recovery among patients in the early stages of mental health problems.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - A brief psychosocial intervention aimed at promoting recovery
Interventions/Control_2 - Treatment as usual
Eligibility:
Age-lower limit - 12
years-old
=
Gender - Male and Female
Key inclusion criteria - 12 to 30 years
Patients with mental disorders
Key exclusion criteria - Inability to communicate in Japanese
Presence of organic brain disorder requiring treatment
Presence of physical disorder requiring inpatient treatment
Subject to behavioral restrictions (seclusion or physical restraint) under the Mental Health and Welfare Act
Target Size - 60
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2022 Year 08 Month 31 Day
Date of IRB - 2022 Year 09 Month 16 Day
Anticipated trial start date - 2022 Year 09 Month 16 Day
Last follow-up date - 2027 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069933
Disclaimer: Curated by HT Syndication.
